How Medical Affairs Can Contribute to Successful Drug Launch
September 16, 2021
The COVID-19 pandemic has brought a range of unprecedented challenges, ushering the pharmaceutical industry and businesses into a new era of how to approach work in more productive and effective ways. The urgency in creating a vaccine to ameliorate the burdens of the pandemic has highlighted the need for greater efficiency within the drug development process, pushing the boundaries of industry to new limits.
Read the source article at PharmExec
2021-09-13 17:00:00